Fel d 1 Monoclonal Antibody Combination Modulates Asthma and Allergic Molecular Pathways in Nasal Mucosa Upon Cat Allergen Challenge in a Phase 2, Randomized, Double-blind, Placebo-controlled Study

Presenting Author(s)

• MO

  Meagan P. O’Brien, MD

  Senior Medical Director
  Regeneron Pharmaceuticals, Inc.
  Tarrytown, New York, United States

  PDF

Chair(s)

• AS

  ANDREY S. Shaw, MD

  Senior Fellow
  Genentech
  South San Francisco, California, United States